Stoke Therapeutics, Inc. - 8-K Filing
Edward M. Kaye resigns as Class III director and member of the Research and Development Committee; Alexander (Bo) Cumbo appointed to fill vacancy. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $STOK